A review of high fat diet-streptozotocin model for induction of type 2 diabetes in rat

Iranian Journal of Endocrinology and Metabolism

Volumn 18, Issue 2, 2016, Pages 143-157

  Gheibi, S ^a   Bakhtiarzadeh, F ^b   Ghasemi, A ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Animal model; High fat diet; Rat; Streptozotocin; Type 2 diabetes

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DESTRUCTION; COST EFFECTIVENESS ANALYSIS; INSULIN RESISTANCE; LIPID DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; REVIEW; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 84979299415     PISSN: 16834844     EISSN: 16835476     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Atkins RC,Zimmet P. Diabetic kidney disease: Act now or pay later. J Bras Nefrol 2010; 32: 7-10.
2. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol 2011; 8: 228-36.
3. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103: 137-49.
4. Wang HJ, Jin YX, Shen W, Neng J, Wu T, Li YJ, et al. Low dose streptozotocin (stz) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac J Clin Nutr 2007; 16: 412-17.
5. Ansarullah Bhavna Bharucha P V, Ramachandran AV. Improved glucoregulation, insulin resistance and leptin levels by a polyherbal drug in high fat diet and low dose streptozotocin type 2 diabetes model. Diabetologia Croatica 2012; 41: 3-15.
6. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005; 52: 313-20.
7. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, et al. A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat. Metabolism 2000; 49: 1390-94.
8. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002; 25: 5-20.
9. Ghasemi A, Khalifi S, Jedi S. Streptozotocin-nicotinamide-induced rat model of type 2 diabetes. Acta Physiol Hung 2014; 101: 408-20.
10. Doan Viet B, Nguyen Thi Kim D, Le Thi Bich T, Nguyen Bich N, Phan Van C. Macro-and microvascular complications of diabetes induced by high-fat diet and low-dose streptozotocin injection in rats model. International Journal of Diabetes Research 2013; 2: 50-5.
11. Irons BK, Minze MG. Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014; 7: 15-24.
12. Szkudelski T. The mechanism of alloxan and streptozotocin action in b cells of the rat pancreas. Physiol Res 2001; 50: 537-46.
13. Islam MS, Wilson RD. Experimentally induced rodent models of type 2 diabetes. Methods Mol Biol 2012; 933: 161-74.
14. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: An overview. Indian J Med Res 2007; 125: 451-72.
15. Masiello P. Animal models of type 2 diabetes with reduced pancreatic b-cell mass. Int J Biochem Cell Biol 2006; 38: 873-93.
16. Wilson RD, Islam MS. Fructose-fed streptozotocin-injected rat: An alternative model for type 2 diabetes. Pharmacol Rep 2012; 64: 129-39.
17. Novelli M, Fabregat M E, Fernandez-Alvarez J, Gomis R, Masiello P. Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol Cell Endocrinol 2001; 175: 57-66.
18. Novelli M, Pocai A, Lajoix A D, Beffy P, Bezzi D, Marchetti P, et al. Alteration of b-cell constitutive no synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes. Mol Cell Endocrinol 2004; 219: 77-82.
19. Zhang M, Lv XY, Li J, Xu ZG, Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008; 2008: 704045.
20. Atanasovska E, Tasic V, Slaninka-Miceska M, Alabakovska S, Zafirov D, Kostova E, et al. Six week followup of metabolic effects induced by a high-fat diet and streptozotocin in a rodent model of type 2 diabetes mellitus. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2014; 35: 169-79.
21. Lu HE, Jian CH, Chen SF, Chen TM, Lee ST, Chang CS, et al. Hypoglycaemic effects of fermented mycelium of paecilomyces farinosus (G30801) on high-fat fed rats with streptozotocin-induced diabetes. Indian J Med Res 2010; 131: 696-701.
22. Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, et al. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int 2005; 68: 2562-71.
23. Zou F, Mao XQ, Wang N, Liu J, Ou-Yang JP. Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation of ampk. Acta Pharmacol Sin 2009; 30: 1607-15.
24. Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, et al. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: The fat-fed, streptozotocin-treated rat. Metabolism 2007; 56: 1233-40.
25. Karasawa H, Nagata-Goto S, Takaishi K, Kumagae Y. A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in bdf1 mice. Metabolism 2009; 58: 296-303.
26. Hu SH, Jiang T, Yang SS, Yang Y. Pioglitazone ameliorates intracerebral insulin resistance and tau-protein hyperphosphorylation in rats with type 2 diabetes. Exp Clin Endocrinol Diabetes 2013; 121: 220-4.
27. Gandhi GR, Stalin A, Balakrishna K, Ignacimuthu S, Paulraj MG, Vishal R. Insulin sensitization via partial agonism of ppar> and glucose uptake through translocation and activation of glut4 in pi3k/p-akt signaling pathway by embelin in type 2 diabetic rats. Biochim Biophys Acta 2013; 1830: 2243-55.
28. Khan HB, Vinayagam KS, Moorthy BT, Palanivelu S, Panchanatham S. Anti-inflammatory and anti-hyperlipidemic effect of semecarpus anacardium in a high fat diet: Stz-induced type 2 diabetic rat model. Inflammopharmacology 2013; 21: 37-46.
29. Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM. Hesperidin and naringin attenuate hyperglycemiamediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications 2012; 26: 483-90.
30. Albersen M, Lin G, Fandel TM, Zhang H, Qiu X, Lin CS, et al. Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetesassociated erectile dysfunction. Urology 2011; 78: 476.e1-8.
31. Abo-elmatty DM, Essawy SS, Badr JM, Sterner O. Antioxidant and anti-inflammatory effects of urtica pilulifera extracts in type 2 diabetic rats. J Ethnopharmacol 2013; 145: 269-77.
32. Skovsø S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig 2014; 5: 349-58.
33. Reeves P G. Components of the ain-93 diets as improvements in the ain-76a diet. J Nutr 1997; 127: 838-41.
34. Gajda A M, Pellizzon M A, Ricci M R, Ulman E A. Diet-induced metabolic syndrome in rodent models. Animal Lab News 2007; 74: 775-93.
35. Flanagan AM, Brown JL, Santiago CA, Aad PY, Spicer LJ, Spicer MT. High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J Nutr Biochem. 2008; 19: 505-13.
36. Medinsky MA, Popp JA, Hamm TE, Dent JG. Development of hepatic lesions in male fischer-344 rats fed ain-76a purified diet. Toxicol Appl Pharmacol 1982; 62: 111-20.
37. Bergstra AE, Lemmens AG, Beynen AC. Dietary fructose vs glucose stimulates nephrocalcinogenesis in female rats. J Nutr 1993; 123: 1320-7.
38. Tierney AC, Roche HM. The potential role of olive oilderived mufa in insulin sensitivity. Mol Nutr Food Res 2007; 51: 1235-48.
39. Zhang F, Ye C, Li G, Ding W, Zhou W, Zhu H, et al. The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp Anim 2003; 52: 401-7.
40. Mansor LS, Gonzalez ER, Cole MA, Tyler DJ, Beeson JH, Clarke K, et al. Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin. Cardiovasc Diabetol 2013; 12: 136.
41. Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, et al. Single dose streptozotocin induced diabetes: Considerations for study design in islet transplantation models. Lab Anim 2011; 45: 131-40.
42. Mcevoy R C. Changes in the volumes of the a-, b-, and d-cell populations in the pancreatic islets during the postnatal development of the rat. Diabetes 1981; 30: 813-7.
43. H.McNeill J.(1999). Experimental models of diabetes.
44. Candela S, Hernandez RE, Gagliardino JJ. Circadian variation of the streptozotocin-diabetogenic effect in mice. Experientia 1979; 35: 1256-7.
45. Tay YC, Wang Y, Kairaitis L, Rangan GK, Zhang C, Harris DC. Can murine diabetic nephropathy be separated from superimposed acute renal failure & quest. Kidney Int 2005; 68: 391-8.
46. Kongkachuichai RP, Surasiang R, Posuwan J, Charoensiri R, Kettawan A, Vanavichit A. Effect of riceberry oil (deep purple oil; oryza sativa indica) supplementation on hyperglycemia and change in lipid profile in streptozotocin (stz)-induced diabetic rats fed a high fat diet. International Food Research Journal 2013; 20: 873-82.
47. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007; 28: 463-91.
48. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985; 248: 286-91.
49. Manning B D. Insulin signaling: Inositol phosphates get into the akt. Cell 2010; 143: 861-3.
50. Mora A, Komander D, van Aalten DM, Alessi DR. PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 2004; 15: 161-70.
51. Sakamoto K, Holman GD. Emerging role for as160/tbc1d4 and tbc1d1 in the regulation of glut4 traffic. Am J Physiol Endocrinol Metab 2008; 295: 29-37.
52. Howlett KF, Sakamoto K, Garnham A, Cameron-Smith D, Hargreaves M. Resistance exercise and insulin regulate as160 and interaction with 14-3-3 in human skeletal muscle. Diabetes 2007; 56: 1608-14.
53. Kohn AD, Summers SA, Birnbaum MJ, Roth RA. Expression of a constitutively active akt ser/thr kinase in 3T3-L1adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996; 271: 31372-8.
54. Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, et al. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3b by the serine-threonine kinase akt. Molecular and Cellular Biology 1999; 19: 6286-96.
55. Turban S, Hajduch E. Protein kinase c isoforms: Mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett 2011; 585: 269-74.
56. Molina JR, Adjei AA. The ras/raf/mapk pathway. Journal of Thoracic Oncology 2006; 1: 7-9.
57. Hiraoka M. A novel action of insulin on cardiac membrane. Circulation Research 2003; 92: 707-09.
58. Formisano P, Fiory F, Caruso M, Miele C, Maitan M A, Andreozzi F, et al. Insulin-activated protein kinase cb bypasses ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Molecular and Cellular Biology 2000; 20: 6323-33.
59. Schubert C, Carel K, DePaolo D, Leitner W, Draznin B. Interactions of protein kinase c with insulin signaling influence on gap and sos activities. J Biol Chem 1996; 27: 15311-4.
60. Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, et al. Role of diacylglycerolregulated protein kinase c isotypes in growth factor activation of the raf-1 protein kinase. Mol Cell Biol 1997; 17: 732-41.
61. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, et al. Protein kinase c alph activates raf-1 by direct phosphorylation. Nature 1993; 364: 249-52.
62. Petersen K F, Shulman GI. Etiology of insulin resistance. Am J Med 2006; 119: S10-6.
63. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (irs-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002; 277: 50230-6.
64. Samuel VT, Shulman GI. Mechanisms for insulin resistance: Common threads and missing links. Cell 2012; 148: 852-71.
65. Chaudhari HS, Bhandari U, Khanna G. Embelia ribes extract reduces high fat and low dose streptozotocininduced diabetic nephrotoxicity in rats. EXCLI J 2013; 12: 858-71.
66. Zhang T, Pan BS, Zhao B, Zhang LM, Huang YL, Sun FY. Exacerbation of posrstroke dementia by type 2 diabetes is associated with synergistic increase of secretase activation and amyloid generation in rat brains. Neuroscience 2009; 161: 1045-56.
67. Ren Z, Li W, Zhao Q, Ma L, Zhu J. The impact of 1,25-dihydroxy vitamin D3 on the expressions of vascular endothelial growth factor and transforming growth factor-b1 in the retinas of rats with diabetes. Diabetes Res Clin Pract 2012; 98: 474-80.
68. Islam MS, Choi H, Loots du T. Effects of dietary onion (allium cepa l.) in a rodent model of high-fat diet streptozotocin-induced diabetes. Ann Nutr Metab 2008; 53: 6-12.
69. Parveen K, Khan R, Siddiqui WA. Antidiabetic effects afforded by terminalia arjuna in high fat-fed and streptozotocin-induced type 2 diabetic rats. Int J Diabetes and Metab 2011; 19: 23-33.
70. Xiao-Hui Xing Z Z, Hu XZ, Wu RQ, Xu C. Antidiabetic effects of artemisia sphaerocephala krasch. Gum, a novel food additive in china, on streptozotocin-induced type 2 diabetic rats. J Ethnopharmacol 2009; 125: 410-6.
71. Xia Y, Li Q, Zhong W, Dong J, Wang Z, Wang C. Lcarnitine ameliorated fatty liver in high-calorie diet/stzinduced type 2 diabetic mice by improving mitochondrial function. Diabetol Metab Syndr 2011; 3: 31.
72. Sankar P, Subhashree S, Sudharani S Effect of trigonella foenum-graecum seed powder on the antioxidant levels of high fat diet and low dose streptozotocin induced type ii diabetic rats. Eur Rev Med Pharmacol Sci 2012; 16: 10-7.
73. Zhao H, Li Z, Tian G, Gao K, Li Z, Zhao B,et al. Effects of traditional chinese medicine on rats with type ii diabetes induced by high-fat diet and streptozotocin: A urine metabonomic study. Afr Health Sci 2013; 13: 673-81.
74. Sahin K, Tuzcu M, Orhan C, Sahin N, Kucuk O, Ozercan IH, et al. Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin. Br J Nutr 2013; 110: 197-205.
75. Swathi M, Priyanka DS. Evaluation of antidiabetic potential of marketed polyherbal formulation (ayurslim) on high fat diet-streptozotocin induced obese diabetic rats. Int J of Biological and Pharmaceutical Research 2012; 3: 524-76.
76. Zhang SH, Reddick RL, Burkey B, Maeda N. Dietinduced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994; 94: 937045.
77. Singh S, Sharma RK, Malhotra S, Pothuraju R, Shandilya UK. Assessment of gut associated changes and adipose tissue inflammation in high fat diet fed streptozotocin-induced diabetic rats. J of Innovative Bio 2014; 1: 68-77.
78. Van Linthout S, Spillmann F, Schultheiss HP, Tschope C. High density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders. Curr Pharm Des 2010; 16: 1504-1.
79. Hou L, Lian K, Yao M, Shi Y, Lu X, Fang L, et al. Reduction of n-3 pufas, specifically dha and epa, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart. Cardiovasc Diabetol 2012; 11: 126.
80. Drucker DJ. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 2003; 26: 2929-40.
81. Byrne FM, Cheetham S, Vickers S, Chapman V. Characterisation of pain responses in the high fat diet/ streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments. J Diabetes Res 2015; 2015: 752481.
82. Eleazu CO, Eleazu KC, Chukwuma S, Essien UN. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord 2013; 12: 60.
83. Lenzen S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 2008; 51: 216-26.
84. Ansuri MI, Patel VM. Evaluation of antidiabetic and antihyperlipidemic activity of euphorbia aneriifolia linn. In high fat diet-streptozotocin induced type-2 diabetic model. Int J For Pharmaceutical Research Scholars 2014; 2: 83-9.
85. Parveen K, Khan MR, Mujeeb M, Siddiqui WA Protective effects of pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem Biol Interact 2010; 186: 219-27.